Vasconcelos, Flavia C <br/><br/>
Age, gender and efflux transporter activity influence imatinib efficacy in chronic myeloid leukemia patients.  [electronic resource] 

 -  Leukemia research  07 2019 
 - 33-35 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-5835 
<br/><br/><label>Standard No.: </label>10.1016/j.leukres.2019.05.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Adult<br/>Age Factors<br/>Antineoplastic Agents--metabolism<br/>B-Lymphocytes--drug effects<br/>Biological Transport<br/>Biomarkers, Tumor--genetics<br/>Female<br/>Humans<br/>Imatinib Mesylate--metabolism<br/>K562 Cells<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Primary Cell Culture<br/>Progesterone--pharmacology<br/>Proto-Oncogene Proteins c-abl--genetics<br/>Sex Factors<br/>Treatment Outcome